What antiemetic should be added to a patient with nausea and vomiting who is already on pantoprazole (Protonix)?

Antiemetic Selection for Nausea/Vomiting in a Patient Already on Pantoprazole

Add metoclopramide 10 mg PO/IV every 6 hours as your first-line antiemetic—it has the strongest evidence for efficacy in nonspecific nausea and vomiting and carries no QT-prolongation risk. 1

First-Line Recommendation: Metoclopramide

• Metoclopramide is the most strongly supported antiemetic for general nausea and vomiting, demonstrating the highest efficacy among dopamine antagonists without cardiac concerns. 1, 2
• Standard dosing is 10 mg PO or IV every 6 hours, with escalation to 10-40 mg every 4-6 hours permitted for breakthrough symptoms when initial dosing proves insufficient. 1
• Keep diphenhydramine 25-50 mg readily available to treat dystonic reactions, which can occur with any dopamine antagonist including metoclopramide. 1

Alternative First-Line Options (if metoclopramide is contraindicated or ineffective)

• Prochlorperazine 10 mg PO/IV every 6 hours (or 25 mg rectal suppository every 12 hours) provides effective dopamine antagonism without QT-prolongation. 1, 3
• Promethazine 12.5-25 mg PO or rectally every 4-6 hours is an alternative, but peripheral IV administration is contraindicated due to risk of tissue injury including gangrene—use central line only if IV route required. 1
• Ondansetron should be avoided as first-line because it is associated with QTc prolongation and requires baseline ECG monitoring before use. 1

Second-Line and Adjunctive Therapies

If nausea persists despite metoclopramide:

• Olanzapine 5-10 mg PO daily carries Category 1 evidence as the most effective second-line option for breakthrough vomiting not controlled by standard antiemetics. 1
• Haloperidol 0.5-2 mg PO or IV every 4-6 hours is effective at antiemetic doses and does not prolong QT interval. 1
• Lorazepam 0.5-2 mg PO/sublingual/IV every 6 hours is useful when anxiety contributes to nausea. 1, 4
• Continue the pantoprazole (which the patient is already taking) as H2-blockers or proton pump inhibitors should be added to any antiemetic regimen to address gastric acid/reflux contributions. 4, 1

Refractory Cases

For persistent vomiting despite first- and second-line therapies:

• Cannabinoids (dronabinol 5-10 mg PO every 4-6 hours or nabilone 1-2 mg PO twice daily) are reserved for refractory cases. 1, 4
• Scopolamine 1.5 mg transdermal patch (changed every 72 hours) is useful if a vestibular or motion-related component is suspected. 1

Critical Safety Considerations

• Monitor for extrapyramidal symptoms (most common with metoclopramide and prochlorperazine); treat promptly with diphenhydramine 25-50 mg PO/IV every 4-6 hours. 1
• Benztropine 1-2 mg IV/IM is an alternative for diphenhydramine-allergic patients. 1
• Use drug-class sequencing: When vomiting persists, sequentially add agents from different pharmacologic classes rather than merely increasing the dose of a single ineffective drug, thereby targeting multiple neurotransmitter pathways. 1

Common Pitfalls to Avoid

• Do not use ondansetron as first-line without ECG monitoring due to QT-prolongation risk, despite its common use in emergency departments. 1, 3
• Avoid peripheral IV promethazine due to risk of tissue necrosis and gangrene. 1
• Do not rely solely on dose escalation of a single agent; instead, add medications from different classes to target multiple receptor systems. 1
• Metoclopramide should be used cautiously in patients with history of leukopenia or seizure disorders. 1